|
|
||||||||
Ann Thorac Surg 2005;80:1699-1705
© 2005 The Society of Thoracic Surgeons
Department of Cardiothoracic Surgery, Heart Center Northrhine-Westfalia, Ruhr University of Bochum, Bad Oeynhausen, Germany
Accepted for publication April 27, 2005.
* Address correspondence to Dr Minami, Department of Cardiothoracic Surgery, Heart Center NRW, University of Bochum, Georgstrasse 11, Bad Oeynhausen, 32545 Germany (Email: kminami{at}hdz-nrw.de).
BACKGROUND: Pericardial prostheses have been used as valvular substitutes since 1975. They combine excellent hemodynamic characteristics with a low risk of valve failure during long-term observation. The aim of this article is to describe the clinical long-term performance of the Mitroflow Synergy pericardial valve (Sorin Group Inc, Mitroflow Division, Vancouver, Canada) in the aortic position for as long as 19 years.
METHODS: Data were obtained between February 1985 and April 2004 from patients with aortic heart valve replacements (n = 1,464) or from patients with replacements of existing prosthetic aortic valves (n = 52). The age group distributions are less than 70 years (n = 175); 70 to 74 years (n = 462); 75 to 79 years (n = 532); 80 to 84 years (n = 273); and greater than or equal to 85 years (n = 74). The cause of the aortic valve lesions was combined (insufficiency and stenosis) in the majority of patients (62.4%). Concomitant procedures were performed in 897 patients (59.2%) and coronary artery bypass grafting was the most common (53.5%). Mean follow-up was 5.5 ± 0.09 years. Total follow-up was 8,408 patient-years.
RESULTS: The early mortality (30 days) was 6.6% (n = 99) and late deaths were 60.8% (n = 921). Actuarial event-free rates at 5, 10, and 15 years of follow-up are given as mean ± standard error for endocarditis: 96.9 ± 0.5, 92.8 ± 1.2, and 92.0 ± 1.4, respectively; embolism: 96.7 ± 0.6, 88.8 ± 1.7, and 82.9 ± 3.5, respectively; bleeding: 98.5 ± 0.4, 97.2 ± 0.6, and 94.4 ± 1.7, respectively; structural valve deterioration: 99.0 ± 0.3, 82.8 ± 2.2, and 62.8 ± 5.8, respectively; and reoperation: 98.2 ± 0.4, 79.2 ± 2.4, and 63.4 ± 5.3, respectively. The rate of endocarditis, structural valve degeneration, and reoperation was lower in patients 75 years of age and older compared with younger patients, whereas embolism occurred more frequently in elderly than in younger patients.
CONCLUSIONS: Adverse events after implantation of Mitroflow aortic bioprosthesis rarely occurred during the first 5 years after valve replacement. The results of the prosthesis indicates reliable long-term morbidity rates and good durability in patients 75 years of age and older.
This article has been cited by other articles:
![]() |
J. Butany, T. Feng, A. Luk, K. Law, R. Suri, and V. Nair Modes of Failure in Explanted Mitroflow Pericardial Valves Ann. Thorac. Surg., November 1, 2011; 92(5): 1621 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
The ISTHMUS Investigators The Italian study on the Mitroflow postoperative results (ISTHMUS): a 20-year, multicentre evaluation of Mitroflow pericardial bioprosthesis Eur J Cardiothorac Surg, January 1, 2011; 39(1): 18 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. E. Jamieson Reply to Quiroga et al. Eur J Cardiothorac Surg, November 1, 2010; 38(5): 649 - 650. [Full Text] [PDF] |
||||
![]() |
J. Sierra Quiroga, J. R. Alvarez, J. M. Martinez-Cereijo, and C. Delgado Mitroflow aortic pericardial bioprosthesis Eur J Cardiothorac Surg, November 1, 2010; 38(5): 649 - 649. [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola Choice of Prosthetic Heart Valve in Adults: An Update J. Am. Coll. Cardiol., June 1, 2010; 55(22): 2413 - 2426. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Alvarez, J. Sierra, M. Vega, B. Adrio, J. Martinez-Comendador, F. Gude, J. Martinez-Cereijo, and J. Garcia Early calcification of the aortic Mitroflow pericardial bioprosthesis in the elderly Interact CardioVasc Thorac Surg, November 1, 2009; 9(5): 842 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. E. Jamieson, R. Koerfer, C. A. Yankah, A. Zittermann, R. I. Hayden, H. Ling, R. Hetzer, and W. B. Dolman Mitroflow aortic pericardial bioprosthesis -- clinical performance, Eur J Cardiothorac Surg, November 1, 2009; 36(5): 818 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S.U. Myken and O. Bech-Hansen A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 76 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Eichinger, I. M. Hettich, D. J. Ruzicka, K. Holper, C. Schricker, S. Bleiziffer, and R. Lange Twenty-Year Experience With the St. Jude Medical Biocor Bioprosthesis in the Aortic Position Ann. Thorac. Surg., October 1, 2008; 86(4): 1204 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Yankah, M. Pasic, M. Musci, J. Stein, C. Detschades, H. Siniawski, and R. Hetzer Aortic valve replacement with the Mitroflow pericardial bioprosthesis: Durability results up to 21 years J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 688 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Koertke, A. Zittermann, G. Tenderich, O. Wagner, M. El-Arousy, A. Krian, J. Ennker, U. Taborski, W. P. Klovekorn, R. Moosdorf, et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II Eur. Heart J., October 2, 2007; 28(20): 2479 - 2484. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., January 23, 2007; 49(3): 361 - 374. [Full Text] [PDF] |
||||
![]() |
H. Koertke, A. Zittermann, O. Wagner, and R. Koerfer Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement Ann. Thorac. Surg., January 1, 2007; 83(1): 24 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Thiene Durability of Valve Bioprostheses and the Need of Careful Examination of Explants Ann. Thorac. Surg., December 1, 2006; 82(6): 2340 - 2341. [Full Text] [PDF] |
||||
![]() |
T. Eitz, D. Fritzsche, G. Kleikamp, A. Zittermann, D. Horstkotte, and R. Korfer Reoperation of the aortic valve in octogenarians. Ann. Thorac. Surg., October 1, 2006; 82(4): 1385 - 1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Bach Invited commentary Ann. Thorac. Surg., November 1, 2005; 80(5): 1705 - 1705. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |